RIGEL PHARMACEUTICALS INC·4

May 11, 7:33 PM ET

Duliege Anne-Marie 4

4 · RIGEL PHARMACEUTICALS INC · Filed May 11, 2018

Insider Transaction Report

Form 4
Period: 2018-05-09
Duliege Anne-Marie
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2018-05-09+150,000150,000 total
    Exercise: $2.11Exp: 2027-02-02Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]On February 2, 2017 the reporting person was granted an option to purchase 150,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -